Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis
This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val...
Saved in:
Published in | Schizophrenia research Vol. 202; pp. 212 - 216 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models. |
---|---|
AbstractList | AbstractThis study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol- O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models. This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models. This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models.This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models. |
Author | Rosen, Cherise Hill, S. Kristian Reilly, James L. Ragozzino, Michael E. Amsbaugh, Hayley M. Marvin, Robert W. Bishop, Jeffrey R. Nelson, Courtney L.M. Sweeney, John A. |
Author_xml | – sequence: 1 givenname: Courtney L.M. surname: Nelson fullname: Nelson, Courtney L.M. organization: Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA – sequence: 2 givenname: Hayley M. surname: Amsbaugh fullname: Amsbaugh, Hayley M. organization: Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA – sequence: 3 givenname: James L. surname: Reilly fullname: Reilly, James L. organization: Department of Psychology, Northwestern University, Chicago, IL, USA – sequence: 4 givenname: Cherise surname: Rosen fullname: Rosen, Cherise organization: Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA – sequence: 5 givenname: Robert W. surname: Marvin fullname: Marvin, Robert W. organization: Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA – sequence: 6 givenname: Michael E. surname: Ragozzino fullname: Ragozzino, Michael E. organization: Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA – sequence: 7 givenname: Jeffrey R. surname: Bishop fullname: Bishop, Jeffrey R. organization: Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN, USA – sequence: 8 givenname: John A. surname: Sweeney fullname: Sweeney, John A. organization: Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA – sequence: 9 givenname: S. Kristian surname: Hill fullname: Hill, S. Kristian email: scot.hill@rosalindfranklin.edu organization: Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29941295$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkl9rFDEUxYNU7Lb6DUTy6MuuN5m_ERHq4j-o9MH6HDKZO-1dZ5MxyS7OZ_BLm3WrD4IUIRAI55xwz--esRPnHTL2VMBKgKhfbFbR3gaMKwmiXUG9AqkesIWommIpK1AnbAFKwlKpujxlZzFuAEBU0Dxip1KpUkhVLdiPN-hwIEtm5Mb13PR7DBE5DgPaFLkf8nOiKc721ieyfIs9WZPIO56P9TeOEu2RDyN-p45GSjM3AXnA0STsefJ8ffXpmt-g82mekJPjA4WYOE4UfY_8mB0pPmYPBzNGfHJ3n7Mv795erz8sL6_ef1xfXC5t1cq07HurRFsNTYmt6KBTAAZRDK0wrRK2h1I2RdV2UhosZCc6k0V1my1F7gNNcc6eH3On4L_tMCa9pWhxHI1Dv4taQqWqumzKKkuf3Ul3XZ5cT4G2Jsz6d4FZUB4FNvgYAw5_JAL0gZPe6CMnfeCkodaZU7a9_MtmKf1qNQVD433m10cz5pL2hCGLCJ3NZEKGpntP_xtgR3IZ6_gVZ4wbvwsuA9BCR6lBfz7s0WGNRFtAURdFDnj174D7__8JQafcnA |
CitedBy_id | crossref_primary_10_3390_biom14070777 crossref_primary_10_3390_diagnostics14161730 crossref_primary_10_1016_j_schres_2020_08_005 crossref_primary_10_3389_fpsyt_2023_1334335 crossref_primary_10_3390_ph15060749 crossref_primary_10_2217_pgs_2022_0070 |
Cites_doi | 10.1177/0269881103017001700 10.1016/j.biopsych.2011.03.028 10.1093/cercor/11.11.1015 10.1086/425589 10.1016/S0006-3223(98)00258-3 10.1016/j.schres.2009.04.020 10.1002/aur.1395 10.1586/ern.09.143 10.1176/ajp.161.10.1798 10.1176/ajp.156.5.780 10.1523/JNEUROSCI.14-05-02531.1994 10.1176/ajp.2007.164.7.1061 10.1001/archpsyc.63.11.1189 10.1016/j.biopsych.2008.05.015 10.1093/schbul/sbm112 10.1016/j.biopsych.2006.10.031 10.1007/s00213-007-0808-x 10.1016/j.biopsych.2004.08.012 10.1126/science.1825731 10.1038/sj.npp.1300542 10.1146/annurev-psych-113011-143750 10.1093/schbul/sbu130 10.1016/j.biopsych.2005.10.024 10.1001/archpsyc.1994.03950060033003 10.1016/j.euroneuro.2007.11.005 10.1037/0735-7044.116.1.105 10.1093/ijnp/pyv132 10.1093/schbul/sbu013 |
ContentType | Journal Article |
Copyright | 2018 Elsevier B.V. Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.schres.2018.06.029 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1573-2509 |
EndPage | 216 |
ExternalDocumentID | 29941295 10_1016_j_schres_2018_06_029 S0920996418303633 1_s2_0_S0920996418303633 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 4H- 53G 5VS 7-5 71M 8P~ 9JM 9JO AABNK AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABIVO ABJNI ABMAC ABMZM ABOYX ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACIUM ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HMQ HMW HVGLF HZ~ IHE J1W KOM M29 M2V M39 M3V M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SPS SSB SSH SSN SSY SSZ T5K WUQ Z5R ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AFYLN AJBFU EFLBG LCYCR AAYXX AGRNS CITATION NPM 7X8 |
ID | FETCH-LOGICAL-c582t-ddc9185f74e81b0b900aee1f81a891cd0427358b22ae32b1bab0b681853920ea3 |
IEDL.DBID | .~1 |
ISSN | 0920-9964 1573-2509 |
IngestDate | Mon Jul 21 11:31:40 EDT 2025 Thu Apr 03 07:08:25 EDT 2025 Tue Jul 01 03:58:53 EDT 2025 Thu Apr 24 22:59:30 EDT 2025 Fri Feb 23 02:33:32 EST 2024 Sun Feb 23 10:19:49 EST 2025 Tue Aug 26 17:10:04 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Psychosis Antipsychotic COMT PCET |
Language | English |
License | Copyright © 2018 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c582t-ddc9185f74e81b0b900aee1f81a891cd0427358b22ae32b1bab0b681853920ea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://figshare.com/articles/journal_contribution/Beneficial_and_adverse_effects_of_antipsychotic_medication_on_cognitive_flexibility_are_related_to_COMT_genotype_in_first_episode_psychosis/22299268 |
PMID | 29941295 |
PQID | 2059564745 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2059564745 pubmed_primary_29941295 crossref_primary_10_1016_j_schres_2018_06_029 crossref_citationtrail_10_1016_j_schres_2018_06_029 elsevier_sciencedirect_doi_10_1016_j_schres_2018_06_029 elsevier_clinicalkeyesjournals_1_s2_0_S0920996418303633 elsevier_clinicalkey_doi_10_1016_j_schres_2018_06_029 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-12-01 |
PublicationDateYYYYMMDD | 2018-12-01 |
PublicationDate_xml | – month: 12 year: 2018 text: 2018-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Schizophrenia research |
PublicationTitleAlternate | Schizophr Res |
PublicationYear | 2018 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Reilly, Sweeney (bb0115) 2014; 40 Hill, Reiley, Harris, Khine, Sweeney (bb0070) 2008; 34 Szeszko, Bilder, Dunlop, Walder, Lieberman (bb0145) 1999; 45 Hagiwara, Fujita, Ishima, Kunitachi, Shirayama, Iyo, Hashimoto (bb0055) 2008; 18 Keefe, Sweeney, Gu, Hamer, Perkins, McEvoy, Lieberman (bb0095) 2007; 164 Merriam, Thase, Haas, Keshavan, Sweeney (bb0105) 1999; 156 Hill, Bishop, Palumbo, Sweeney (bb0080) 2010; 10 Huang, Zai, Lisoway, Maciukiewicz, Felsky, Tiwari, Kennedy (bb0090) 2016; 19 Abdul-Monim, Reynolds, Neill (bb0005) 2003; 17 Weickert, Goldberg, Mishara, Apud, Kolachana, Egan, Weinberger (bb0155) 2004; 56 Crofts, Dalley, Van Denderen, Everitt, Robbins, Robers (bb0045) 2001; 11 Tunbridge, Harrison, Weinberger (bb0150) 2006; 60 Durstewitz, Seamans (bb4000) 2008; 64 Diamond (bb0050) 2013; 64 Reilly, Harris, Khine, Keshavan, Sweeney (bb0125) 2007; 62 Reilly, Harris, Keshavan, Sweeney (bb0120) 2006; 63 Hill, Reiley, Harris, Rosen, Marvin, DeLeon, Sweeney (bb0075) 2009; 113 Chen, Lipska, Halim, Ma, Matsumoto, Melhem, Kolachana, Weinberger (bb0035) 2004; 75 Heaton, Paulsen, McAdams, Kuch, Zisook, Braff, Harris, Jeste (bb0065) 1994; 51 Amitai, Semenova, Markou (bb0010) 2007; 193 Bertolino, Caforio, Blasi, De Candia, Latorre, Petruzzella, Altamura, Nappi, Papa, Callicott, Mattay (bb0020) 2004; 161 Hill, Reiley, Ragozzino, Rubin, Sweeney (bb0085) 2015; 41 Amodeo, Jones, Sweeney, Ragozzino (bb0015) 2014; 7 Sawaguchi, Goldman-Raikic (bb0135) 1991; 251 Bilder, Volavka, Lachman, Grace (bb0025) 2004; 29 Cools, D'Esposito (bb0040) 2011; 69 Roberts, De Salvia, Wilkinson, Collins, Muir, Everitt, Robbins (bb0130) 1994; 14 Ragozzino, Ragozzino, Mizumori, Kesner (bb0110) 2002; 116 Amodeo (10.1016/j.schres.2018.06.029_bb0015) 2014; 7 Hill (10.1016/j.schres.2018.06.029_bb0085) 2015; 41 Hagiwara (10.1016/j.schres.2018.06.029_bb0055) 2008; 18 Reilly (10.1016/j.schres.2018.06.029_bb0115) 2014; 40 Ragozzino (10.1016/j.schres.2018.06.029_bb0110) 2002; 116 Tunbridge (10.1016/j.schres.2018.06.029_bb0150) 2006; 60 Sawaguchi (10.1016/j.schres.2018.06.029_bb0135) 1991; 251 Amitai (10.1016/j.schres.2018.06.029_bb0010) 2007; 193 Reilly (10.1016/j.schres.2018.06.029_bb0120) 2006; 63 Keefe (10.1016/j.schres.2018.06.029_bb0095) 2007; 164 Szeszko (10.1016/j.schres.2018.06.029_bb0145) 1999; 45 Chen (10.1016/j.schres.2018.06.029_bb0035) 2004; 75 Merriam (10.1016/j.schres.2018.06.029_bb0105) 1999; 156 Crofts (10.1016/j.schres.2018.06.029_bb0045) 2001; 11 Heaton (10.1016/j.schres.2018.06.029_bb0065) 1994; 51 Bilder (10.1016/j.schres.2018.06.029_bb0025) 2004; 29 Bertolino (10.1016/j.schres.2018.06.029_bb0020) 2004; 161 Hill (10.1016/j.schres.2018.06.029_bb0070) 2008; 34 Huang (10.1016/j.schres.2018.06.029_bb0090) 2016; 19 Weickert (10.1016/j.schres.2018.06.029_bb0155) 2004; 56 Roberts (10.1016/j.schres.2018.06.029_bb0130) 1994; 14 Abdul-Monim (10.1016/j.schres.2018.06.029_bb0005) 2003; 17 Durstewitz (10.1016/j.schres.2018.06.029_bb4000) 2008; 64 Hill (10.1016/j.schres.2018.06.029_bb0080) 2010; 10 Diamond (10.1016/j.schres.2018.06.029_bb0050) 2013; 64 Reilly (10.1016/j.schres.2018.06.029_bb0125) 2007; 62 Cools (10.1016/j.schres.2018.06.029_bb0040) 2011; 69 Hill (10.1016/j.schres.2018.06.029_bb0075) 2009; 113 |
References_xml | – volume: 193 start-page: 521 year: 2007 end-page: 537 ident: bb0010 article-title: Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats publication-title: Psychopharmacology – volume: 164 start-page: 1061 year: 2007 end-page: 1071 ident: bb0095 article-title: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison publication-title: Am. J. Psychiatry – volume: 161 start-page: 1798 year: 2004 end-page: 1805 ident: bb0020 article-title: Interaction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia publication-title: Am. J. Psychiatry – volume: 69 start-page: 113 year: 2011 end-page: 125 ident: bb0040 article-title: Inverted u-shaped dopamine actions on human working memory and cognitive control publication-title: Biol. Psychiatry – volume: 17 start-page: 57 year: 2003 end-page: 66 ident: bb0005 article-title: The atypical antipsychotic ziprasisdone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat publication-title: J. Psychopharmacol. – volume: 56 start-page: 677 year: 2004 end-page: 682 ident: bb0155 article-title: Catechol-o-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications publication-title: Biol. Psychiatry – volume: 64 start-page: 135 year: 2013 end-page: 168 ident: bb0050 article-title: Executive functions publication-title: Annu. Rev. Psychol. – volume: 19 start-page: 1 year: 2016 end-page: 12 ident: bb0090 article-title: Catechol-o-methyltransferase val158met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta analysis publication-title: Int. J. Neuropsychopharmacol. – volume: 156 start-page: 780 year: 1999 end-page: 782 ident: bb0105 article-title: Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance publication-title: Am. J. Psychatriy – volume: 60 start-page: 141 year: 2006 end-page: 151 ident: bb0150 article-title: Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond publication-title: Biol. Psychiatry – volume: 11 start-page: 1015 year: 2001 end-page: 1026 ident: bb0045 article-title: Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set publication-title: Cereb. Cortex – volume: 63 start-page: 1189 year: 2006 end-page: 1197 ident: bb0120 article-title: Adverse effects of risperidone on spatial working memory in first-episode schizophrenia publication-title: Arch. Gen. Psychiatry – volume: 251 start-page: 947 year: 1991 end-page: 950 ident: bb0135 article-title: D1 dopamine receptors in prefrontal cortex: involvement in working memory publication-title: Science – volume: 64 start-page: 739 year: 2008 end-page: 749 ident: bb4000 article-title: The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia publication-title: Biol. Psychiatry. – volume: 40 start-page: 516 year: 2014 end-page: 522 ident: bb0115 article-title: Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluation pharmacological treatment effects and as intermediate phenotypes for gene discovery publication-title: Schizophr. Bull. – volume: 14 start-page: 2531 year: 1994 end-page: 2544 ident: bb0130 article-title: 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: possible interactions with subcortical dopamine publication-title: J. Neurosci. – volume: 10 start-page: 43 year: 2010 end-page: 57 ident: bb0080 article-title: Effect of second-generation antipsychotics on cognition: current issues and future challenges publication-title: Expert. Rev. Neurother. – volume: 34 start-page: 494 year: 2008 end-page: 506 ident: bb0070 article-title: Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia publication-title: Schizophr. Bull. – volume: 116 start-page: 105 year: 2002 end-page: 115 ident: bb0110 article-title: Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning publication-title: Behav. Neurosci. – volume: 75 start-page: 807 year: 2004 end-page: 821 ident: bb0035 article-title: Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain publication-title: Am. J. Hum. Genet. – volume: 45 start-page: 680 year: 1999 end-page: 686 ident: bb0145 article-title: Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases publication-title: Biol. Psychiatry – volume: 113 start-page: 167 year: 2009 end-page: 175 ident: bb0075 article-title: A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia publication-title: Schizophr. Res. – volume: 41 start-page: 940 year: 2015 end-page: 950 ident: bb0085 article-title: Regressing to prior response set after switching implicates striatal dysfunction across psychotic disorders: findings from the B-SNIP study publication-title: Schizophr. Bull. – volume: 18 start-page: 448 year: 2008 end-page: 454 ident: bb0055 article-title: Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors publication-title: Eur. Neuropsychopharmacol. – volume: 51 start-page: 469 year: 1994 end-page: 476 ident: bb0065 article-title: Neuropsychological deficits in schizophrenics publication-title: Arch. Gen. Psychiatry – volume: 29 start-page: 1943 year: 2004 end-page: 1961 ident: bb0025 article-title: The catechol-o-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes publication-title: Neuropsychopharmacology – volume: 62 start-page: 818 year: 2007 end-page: 821 ident: bb0125 article-title: Antipsychotic drugs exacerbate impairments on a working memory task in first-episode schizophrenia publication-title: Biol. Psychiatry – volume: 7 start-page: 555 year: 2014 end-page: 567 ident: bb0015 article-title: Risperidone and the 5-HT publication-title: Autism Res. – volume: 17 start-page: 57 issue: 1 year: 2003 ident: 10.1016/j.schres.2018.06.029_bb0005 article-title: The atypical antipsychotic ziprasisdone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat publication-title: J. Psychopharmacol. doi: 10.1177/0269881103017001700 – volume: 69 start-page: 113 year: 2011 ident: 10.1016/j.schres.2018.06.029_bb0040 article-title: Inverted u-shaped dopamine actions on human working memory and cognitive control publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2011.03.028 – volume: 11 start-page: 1015 year: 2001 ident: 10.1016/j.schres.2018.06.029_bb0045 article-title: Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set publication-title: Cereb. Cortex doi: 10.1093/cercor/11.11.1015 – volume: 75 start-page: 807 year: 2004 ident: 10.1016/j.schres.2018.06.029_bb0035 article-title: Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain publication-title: Am. J. Hum. Genet. doi: 10.1086/425589 – volume: 45 start-page: 680 issue: 6 year: 1999 ident: 10.1016/j.schres.2018.06.029_bb0145 article-title: Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(98)00258-3 – volume: 113 start-page: 167 issue: 2–3 year: 2009 ident: 10.1016/j.schres.2018.06.029_bb0075 article-title: A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia publication-title: Schizophr. Res. doi: 10.1016/j.schres.2009.04.020 – volume: 7 start-page: 555 issue: 5 year: 2014 ident: 10.1016/j.schres.2018.06.029_bb0015 article-title: Risperidone and the 5-HT2A receptor antagonist, M100907 improve probabilistic reversal learning in BTBR T+ tf/J mice publication-title: Autism Res. doi: 10.1002/aur.1395 – volume: 10 start-page: 43 issue: 1 year: 2010 ident: 10.1016/j.schres.2018.06.029_bb0080 article-title: Effect of second-generation antipsychotics on cognition: current issues and future challenges publication-title: Expert. Rev. Neurother. doi: 10.1586/ern.09.143 – volume: 161 start-page: 1798 year: 2004 ident: 10.1016/j.schres.2018.06.029_bb0020 article-title: Interaction of COMT Val108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia publication-title: Am. J. Psychiatry doi: 10.1176/ajp.161.10.1798 – volume: 156 start-page: 780 issue: 5 year: 1999 ident: 10.1016/j.schres.2018.06.029_bb0105 article-title: Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance publication-title: Am. J. Psychatriy doi: 10.1176/ajp.156.5.780 – volume: 14 start-page: 2531 issue: 5 year: 1994 ident: 10.1016/j.schres.2018.06.029_bb0130 article-title: 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: possible interactions with subcortical dopamine publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.14-05-02531.1994 – volume: 164 start-page: 1061 issue: 7 year: 2007 ident: 10.1016/j.schres.2018.06.029_bb0095 article-title: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison publication-title: Am. J. Psychiatry doi: 10.1176/ajp.2007.164.7.1061 – volume: 63 start-page: 1189 issue: 11 year: 2006 ident: 10.1016/j.schres.2018.06.029_bb0120 article-title: Adverse effects of risperidone on spatial working memory in first-episode schizophrenia publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.11.1189 – volume: 64 start-page: 739 year: 2008 ident: 10.1016/j.schres.2018.06.029_bb4000 article-title: The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia publication-title: Biol. Psychiatry. doi: 10.1016/j.biopsych.2008.05.015 – volume: 34 start-page: 494 issue: 3 year: 2008 ident: 10.1016/j.schres.2018.06.029_bb0070 article-title: Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbm112 – volume: 62 start-page: 818 year: 2007 ident: 10.1016/j.schres.2018.06.029_bb0125 article-title: Antipsychotic drugs exacerbate impairments on a working memory task in first-episode schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.10.031 – volume: 193 start-page: 521 issue: 4 year: 2007 ident: 10.1016/j.schres.2018.06.029_bb0010 article-title: Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats publication-title: Psychopharmacology doi: 10.1007/s00213-007-0808-x – volume: 56 start-page: 677 year: 2004 ident: 10.1016/j.schres.2018.06.029_bb0155 article-title: Catechol-o-methyltransferase Val108/158Met genotype predicts working memory response to antipsychotic medications publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2004.08.012 – volume: 251 start-page: 947 issue: 4996 year: 1991 ident: 10.1016/j.schres.2018.06.029_bb0135 article-title: D1 dopamine receptors in prefrontal cortex: involvement in working memory publication-title: Science doi: 10.1126/science.1825731 – volume: 29 start-page: 1943 year: 2004 ident: 10.1016/j.schres.2018.06.029_bb0025 article-title: The catechol-o-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300542 – volume: 64 start-page: 135 year: 2013 ident: 10.1016/j.schres.2018.06.029_bb0050 article-title: Executive functions publication-title: Annu. Rev. Psychol. doi: 10.1146/annurev-psych-113011-143750 – volume: 41 start-page: 940 issue: 4 year: 2015 ident: 10.1016/j.schres.2018.06.029_bb0085 article-title: Regressing to prior response set after switching implicates striatal dysfunction across psychotic disorders: findings from the B-SNIP study publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbu130 – volume: 60 start-page: 141 issue: 2 year: 2006 ident: 10.1016/j.schres.2018.06.029_bb0150 article-title: Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2005.10.024 – volume: 51 start-page: 469 year: 1994 ident: 10.1016/j.schres.2018.06.029_bb0065 article-title: Neuropsychological deficits in schizophrenics publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1994.03950060033003 – volume: 18 start-page: 448 issue: 6 year: 2008 ident: 10.1016/j.schres.2018.06.029_bb0055 article-title: Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2007.11.005 – volume: 116 start-page: 105 year: 2002 ident: 10.1016/j.schres.2018.06.029_bb0110 article-title: Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning publication-title: Behav. Neurosci. doi: 10.1037/0735-7044.116.1.105 – volume: 19 start-page: 1 issue: 5 year: 2016 ident: 10.1016/j.schres.2018.06.029_bb0090 article-title: Catechol-o-methyltransferase val158met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta analysis publication-title: Int. J. Neuropsychopharmacol. doi: 10.1093/ijnp/pyv132 – volume: 40 start-page: 516 issue: 3 year: 2014 ident: 10.1016/j.schres.2018.06.029_bb0115 article-title: Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluation pharmacological treatment effects and as intermediate phenotypes for gene discovery publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbu013 |
SSID | ssj0001507 |
Score | 2.313161 |
Snippet | This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion... AbstractThis study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 212 |
SubjectTerms | Antipsychotic COMT PCET Psychiatric/Mental Health Psychosis |
Title | Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0920996418303633 https://www.clinicalkey.es/playcontent/1-s2.0-S0920996418303633 https://dx.doi.org/10.1016/j.schres.2018.06.029 https://www.ncbi.nlm.nih.gov/pubmed/29941295 https://www.proquest.com/docview/2059564745 |
Volume | 202 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqcuGCqPhaCtUgcQ2b-GMTH8uKagG1HGil3iw7caQglKya9MCFP8Cf7oztLCCKipBy2chOdu3xzJv1m2fGXrcut5UUIhPclplsMWF1NS-yorYSAXlbC0nVyKdnq82F_HCpLvfYeq6FIVpl8v3Rpwdvne4s02gut123_JxrKvtcSTRK2o0kxU8pS7LyN99_0jwI8AS9PUyTqPVcPhc4XphAYlJLBK-o4hmA5q3h6W_wM4Shk4fsQcKPcBy_4gHb8_0j9uMteqwoBQG2b8DSKcujh0TWgKHF21OXKq66GsKOepgTwGtHIYKW5DEDXfYb2CsPodLFNzANsP50eg6k6Ep_2kLXQ9shcAS_7cah8RCfPXbjY3Zx8u58vcnSKQtZrSo-ZU1TawzabSk9Qtjc6Ty33hdtVdhKF3VDh3EIVTnOrRfcFc5io1WI8zim3oonbL8fev-MgZRWaCu8Vo5EbZTjjW5EWejK-hyNYcHEPLimThLkdBLGVzNzzb6YOCWGpsQQ5Y7rBct2vbZRguOO9mqeNzOXl6JDNBgj7uhX3tbPj2lVj6YwIze5-cPyfu35m_H-wztfzYZlcF3TZo3t_XBNjRSmrrKUasGeRovb_XqEEBJxmnr-3-89ZPfpU-TlvGD709W1f4noanJHYfkcsXvH7z9uzm4AQl8mNA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcClAvHaQmGQuIZN_NjER7qiWqBbDmyl3iwncaQglKya9MCFP8CfZsZ2FhBFRUg5JXYe9njmm_ibGcZeNWVqCylEIrjNE9mgw1pWPEuyykoE5E0lJEUjr88Wq3P5_kJd7LHlFAtDtMqo-4NO99o6npnH0Zxv23b-KdUU9rmQKJS0GylusdsSly-VMXj97SfPgxCPT7iHfhI1n-LnPMkLPUj0aonhFdJ4eqR5rX36G_70dujkHjuIABLehHe8z_Zc94B9P0aVFXJBgO1qsFRmeXAQ2RrQN3h6bGPIVVuB31L3kwJ47DhE0FB-TM-X_Qr20oEPdXE1jD0sP643QCld6a8ttB00LSJHcNt26GsH4d5DOzxk5ydvN8tVEsssJJUq-JjUdaXRaje5dIhh01KnqXUua4rMFjqraqrGIVRRcm6d4GVWWmy08IYex9RZ8Yjtd33nnjCQ0gpthdOqpKw2quS1rkWe6cK6FKVhxsQ0uKaKOcipFMYXM5HNPpswJYamxBDnjusZS3a9tiEHxw3t1TRvZoovRY1o0Ejc0C-_rp8b4rIeTGYGblLzh-j92vM36f2HZ76cBMvgwqbdGtu5_ooaKfRdZS7VjD0OErf7esQQEoGaOvzv575gd1ab9ak5fXf24Sm7S1cCSecZ2x8vr9wRQq2xfO6X0g-6kyfC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beneficial+and+adverse+effects+of+antipsychotic+medication+on+cognitive+flexibility+are+related+to+COMT+genotype+in+first+episode+psychosis&rft.jtitle=Schizophrenia+research&rft.au=Nelson%2C+Courtney+L+M&rft.au=Amsbaugh%2C+Hayley+M&rft.au=Reilly%2C+James+L&rft.au=Rosen%2C+Cherise&rft.date=2018-12-01&rft.eissn=1573-2509&rft.volume=202&rft.spage=212&rft_id=info:doi/10.1016%2Fj.schres.2018.06.029&rft_id=info%3Apmid%2F29941295&rft.externalDocID=29941295 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09209964%2FS0920996418X00127%2Fcov150h.gif |